REGENERON PHARMACEUTICALS, INC. — DEF 14A Filings
30 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by REGENERON PHARMACEUTICALS, INC. (REGN), sorted by most recent first. Each row links to the full filing on EdgarLookup. REGENERON PHARMACEUTICALS, INC. has filed 30 DEF 14A documents with the SEC since 2017. To view all SEC filings by REGENERON PHARMACEUTICALS, INC., see the full filings list.
All
10-K
10-K/A
10-Q
13F-HR
144
15-12G
3
4
4/A
424B1
424B3
424B4
424B5
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFN14A
DEFS14A
FWP
POS EX
PRE 14A
PRES14A
PX14A6G
REGDEX
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001308179-25-000518 | Apr 29, 2025 | Jun 13, 2025 |
| DEF 14A | REGENERON PHARMACEUTICALS, INC. - DEF 14A | 0001308179-24-000577 | Apr 25, 2024 | Jun 14, 2024 |
| DEF 14A | REGENERON PHARMACEUTICALS, INC. - DEF 14A | 0001308179-23-000728 | Apr 21, 2023 | — |
| DEF 14A | — | 0000930413-22-000787 | Apr 21, 2022 | Jun 10, 2022 |
| DEF 14A | — | 0000930413-21-000869 | Apr 23, 2021 | Jun 11, 2021 |
| DEF 14A | — | 0000930413-20-001198 | Apr 24, 2020 | Jun 12, 2020 |
| DEF 14A | — | 0000930413-19-001350 | Apr 26, 2019 | Jun 14, 2019 |
| DEF 14A | DEF 14A | 0001047469-18-003073 | Apr 23, 2018 | Jun 8, 2018 |
| DEF 14A | DEF 14A | 0001104659-17-025609 | Apr 25, 2017 | Jun 9, 2017 |
| DEF 14A | DEF 14A | 0001047469-16-012560 | Apr 26, 2016 | Jun 10, 2016 |
| DEF 14A | DEF 14A | 0001047469-15-003736 | Apr 21, 2015 | Jun 12, 2015 |
| DEF 14A | DEF 14A | 0001193125-14-157198 | Apr 24, 2014 | Jun 13, 2014 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001193125-13-178388 | Apr 29, 2013 | Jun 14, 2013 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-12-001697 | Apr 26, 2012 | Jun 8, 2012 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-11-001031 | Apr 28, 2011 | Jun 10, 2011 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-10-001040 | Apr 27, 2010 | Jun 11, 2010 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-09-000860 | Apr 24, 2009 | Jun 12, 2009 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001206774-08-000874 | Apr 28, 2008 | Jun 13, 2008 |
| DEF 14A | NOTICE OF PROXY STATEMENT | 0001206774-07-001113 | Apr 24, 2007 | Jun 8, 2007 |
| DEF 14A | — | 0001206774-06-000842 | Apr 21, 2006 | Jun 9, 2006 |
| DEF 14A | — | 0001206774-05-000747 | Apr 29, 2005 | Jun 10, 2005 |
| DEF 14A | — | 0001206774-04-001683 | Nov 29, 2004 | Nov 17, 2004 |
| DEF 14A | — | 0001206774-04-000384 | Apr 23, 2004 | Jun 11, 2004 |
| DEF 14A | REGENERON PHARMACEUTICALS, INC. | 0000950123-03-005127 | May 1, 2003 | Jun 13, 2003 |
| DEF 14A | REGENERON PHARMACEUTICALS, INC. | 0000950123-02-004815 | May 8, 2002 | Jun 14, 2002 |
| DEF 14A | REGENERON PHARMACEUTICALS, INC. | 0000950123-01-501439 | Apr 30, 2001 | Jun 8, 2001 |
| DEF 14A | SCHEDULE 14A | 0000889812-00-002043 | May 1, 2000 | Jun 9, 2000 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0000889812-99-001353 | Apr 30, 1999 | Jun 11, 1999 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001024739-98-000464 | Apr 30, 1998 | Jun 12, 1998 |
| DEF 14A | DEFINITIVE PROXY MATERIALS | 0000889812-97-001264 | May 28, 1997 | Jun 27, 1997 |